drugset / Trial / NCT03430037

Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women

NCT03430037

Phase 2 Enrolling by invitation 40 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical dysfunction in elderly women with gait disturbance. Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction.

Timeline

Start
2018-02-06
Primary completion
2026-11
Completion
2027-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fisetin Small molecule 20 mg/kg Oral

Indications